Paul Korner - Jan 19, 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Sr. VP and CMO
Signature
/s/ Geoffrey P. Gilmore, Attorney-in-fact
Stock symbol
AGRX
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 08:31 PM
Next filing
Nov 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +225K $0.00 225K Jan 19, 2022 Common Stock 225K $0.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 19, 2026.